Letter: Diabetes, HL-A antigens, and congenital rubella.
D000328:Adult; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000276:immunology*; D004035:Diet Therapy; D005260:Female; D006680:HLA Antigens / Q000302:isolation & purification*; D006649:Histocompatibility Antigens / Q000302:isolation & purification*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D010629:Phenformin / Q000627:therapeutic use; D012409:Rubella / Q000150:complications / Q000151:congenital* / Q000276:immunology; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D006680:HLA Antigens; D006649:Histocompatibility Antigens; D007328:Insulin; D013453:Sulfonylurea Compounds; D010629:Phenformin